Prairie Wealth Advisors Inc. Decreases Stake in SPDR S&P Biotech ETF $XBI

Prairie Wealth Advisors Inc. reduced its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,091 shares of the exchange traded fund’s stock after selling 300 shares during the period. Prairie Wealth Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Quaker Wealth Management LLC boosted its stake in shares of SPDR S&P Biotech ETF by 101.2% in the 2nd quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 53,536 shares during the last quarter. Strategic Financial Services Inc. lifted its position in SPDR S&P Biotech ETF by 7.2% during the second quarter. Strategic Financial Services Inc. now owns 281,347 shares of the exchange traded fund’s stock valued at $23,332,000 after purchasing an additional 18,778 shares in the last quarter. Mizuho Markets Americas LLC lifted its position in SPDR S&P Biotech ETF by 24.8% during the second quarter. Mizuho Markets Americas LLC now owns 64,470 shares of the exchange traded fund’s stock valued at $5,346,000 after purchasing an additional 12,820 shares in the last quarter. United Capital Management of KS Inc. lifted its position in SPDR S&P Biotech ETF by 2.9% during the second quarter. United Capital Management of KS Inc. now owns 184,347 shares of the exchange traded fund’s stock valued at $15,288,000 after purchasing an additional 5,110 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new position in SPDR S&P Biotech ETF during the second quarter valued at $546,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $110.96 on Thursday. The company has a market capitalization of $6.81 billion, a PE ratio of 11.47 and a beta of 0.93. The business’s fifty day moving average is $99.41 and its 200 day moving average is $88.76. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $112.61.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.